Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting.

Baldin AV, Savvateeva LV, Bazhin AV, Zamyatnin AA Jr.

Cancers (Basel). 2020 Mar 5;12(3). pii: E590. doi: 10.3390/cancers12030590. Review.

2.

Targeting G protein-coupled receptors in cancer therapy.

Soond SM, Zamyatnin AA Jr.

Adv Cancer Res. 2020;145:49-97. doi: 10.1016/bs.acr.2019.11.002. Epub 2019 Dec 20.

PMID:
32089165
3.

Comparative lipidomic analysis of inflammatory mediators in the aqueous humor and tear fluid of humans and rabbits.

Chistyakov DV, Azbukina NV, Astakhova AA, Goriainov SV, Chistyakov VV, Tiulina VV, Baksheeva VE, Kotelin VI, Fedoseeva EV, Zamyatnin AA Jr, Philippov PP, Kiseleva OA, Bessmertny AM, Senin II, Iomdina EN, Sergeeva MG, Zernii EY.

Metabolomics. 2020 Feb 12;16(2):27. doi: 10.1007/s11306-020-1650-y.

PMID:
32052201
4.

Cellular Aging Characteristics and Their Association with Age-Related Disorders.

Rudzińska M, Parodi A, Balakireva AV, Chepikova OE, Venanzi FM, Zamyatnin AA Jr.

Antioxidants (Basel). 2020 Jan 22;9(2). pii: E94. doi: 10.3390/antiox9020094. Review.

5.

Mechanisms and Treatment of Light-Induced Retinal Degeneration-Associated Inflammation: Insights from Biochemical Profiling of the Aqueous Humor.

Chistyakov DV, Baksheeva VE, Tiulina VV, Goriainov SV, Azbukina NV, Gancharova OS, Arifulin EA, Komarov SV, Chistyakov VV, Tikhomirova NK, Zamyatnin AA, Philippov PP, Senin II, Sergeeva MG, Zernii EY.

Int J Mol Sci. 2020 Jan 21;21(3). pii: E704. doi: 10.3390/ijms21030704.

6.

Membrane Binding of Neuronal Calcium Sensor-1: Highly Specific Interaction with Phosphatidylinositol-3-Phosphate.

Baksheeva VE, Nemashkalova EL, Firsov AM, Zalevsky AO, Vladimirov VI, Tikhomirova NK, Philippov PP, Zamyatnin AA Jr, Zinchenko DV, Antonenko YN, Permyakov SE, Zernii EY.

Biomolecules. 2020 Jan 21;10(2). pii: E164. doi: 10.3390/biom10020164.

7.

Emerging Concepts and Challenges in Rheumatoid Arthritis Gene Therapy.

Deviatkin AA, Vakulenko YA, Akhmadishina LV, Tarasov VV, Beloukhova MI, Zamyatnin AA Jr, Lukashev AN.

Biomedicines. 2020 Jan 9;8(1). pii: E9. doi: 10.3390/biomedicines8010009. Review.

8.

Duodenal Ulceration in a Child with Coeliac Disease.

Lototskaya PS, Manina MA, Tertychnyy AS, Zamyatnin AA Jr, Erdes SI.

Diagnostics (Basel). 2020 Jan 9;10(1). pii: E31. doi: 10.3390/diagnostics10010031.

9.

Harnessing the Potential of Killers and Altruists within the Microbial Community: A Possible Alternative to Antibiotic Therapy?

Ikryannikova LN, Kurbatov LK, Soond SM, Zamyatnin AA Jr.

Antibiotics (Basel). 2019 Nov 21;8(4). pii: E230. doi: 10.3390/antibiotics8040230. Review.

10.

Lost or Forgotten: The nuclear cathepsin protein isoforms in cancer.

Soond SM, Kozhevnikova MV, Frolova AS, Savvateeva LV, Plotnikov EY, Townsend PA, Han YP, Zamyatnin AA Jr.

Cancer Lett. 2019 Oct 10;462:43-50. doi: 10.1016/j.canlet.2019.07.020. Epub 2019 Aug 2.

PMID:
31381961
11.

Novel applications of modification of thiol enzymes and redox-regulated proteins using S-methyl methanethiosulfonate (MMTS).

Makarov VA, Tikhomirova NK, Savvateeva LV, Petushkova AI, Serebryakova MV, Baksheeva VE, Gorokhovets NV, Zernii EY, Zamyatnin AA Jr.

Biochim Biophys Acta Proteins Proteom. 2019 Nov;1867(11):140259. doi: 10.1016/j.bbapap.2019.07.012. Epub 2019 Jul 31.

PMID:
31376523
12.

The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.

Rudzińska M, Parodi A, Soond SM, Vinarov AZ, Korolev DO, Morozov AO, Daglioglu C, Tutar Y, Zamyatnin AA Jr.

Int J Mol Sci. 2019 Jul 23;20(14). pii: E3602. doi: 10.3390/ijms20143602. Review.

13.

Experimental Insight into the Structural and Functional Roles of the 'Black' and 'Gray' Clusters in Recoverin, a Calcium Binding Protein with Four EF-Hand Motifs.

Permyakov SE, Vologzhannikova AS, Nemashkalova EL, Kazakov AS, Denesyuk AI, Denessiouk K, Baksheeva VE, Zamyatnin AA Jr, Zernii EY, Uversky VN, Permyakov EA.

Molecules. 2019 Jul 8;24(13). pii: E2494. doi: 10.3390/molecules24132494.

14.

Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis.

Nemtsova MV, Zaletaev DV, Bure IV, Mikhaylenko DS, Kuznetsova EB, Alekseeva EA, Beloukhova MI, Deviatkin AA, Lukashev AN, Zamyatnin AA Jr.

Front Genet. 2019 Jun 14;10:570. doi: 10.3389/fgene.2019.00570. eCollection 2019. Review.

15.

Cutting Out the Gaps Between Proteases and Programmed Cell Death.

Balakireva AV, Zamyatnin AA Jr.

Front Plant Sci. 2019 Jun 4;10:704. doi: 10.3389/fpls.2019.00704. eCollection 2019.

16.

'Patchiness' and basic cancer research: unravelling the proteases.

Soond SM, Kozhevnikova MV, Zamyatnin AA Jr.

Cell Cycle. 2019 Aug;18(15):1687-1701. doi: 10.1080/15384101.2019.1632639. Epub 2019 Jun 24.

PMID:
31213124
17.

Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer.

Soond SM, Kozhevnikova MV, Townsend PA, Zamyatnin AA Jr.

Pharmaceuticals (Basel). 2019 Jun 11;12(2). pii: E87. doi: 10.3390/ph12020087. Review.

18.

Albumin Nanovectors in Cancer Therapy and Imaging.

Parodi A, Miao J, Soond SM, Rudzińska M, Zamyatnin AA Jr.

Biomolecules. 2019 Jun 5;9(6). pii: E218. doi: 10.3390/biom9060218. Review.

19.

Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer.

Parodi A, Rudzińska M, Deviatkin AA, Soond SM, Baldin AV, Zamyatnin AA Jr.

Pharmaceutics. 2019 May 24;11(5). pii: E245. doi: 10.3390/pharmaceutics11050245. Review.

20.

Proteins in Pharmacology: Restrictions, Challenges and Opportunities.

Zamyatnin AA.

Curr Med Chem. 2019;26(3):362-364. doi: 10.2174/092986732603190326151415. No abstract available.

PMID:
30957720

Supplemental Content

Loading ...
Support Center